Patients with severe mental illness and hepatitis C virus infection benefit from new pangenotypic direct-acting antivirals: Results of a literature review
Metadatos
Mostrar el registro completo del ítemAutor
Gutiérrez Rojas, LuisEditorial
Elsevier
Materia
HCV infection Mental illness Schizophrenia Bipolar disorder Antivirals
Fecha
2022-06-17Referencia bibliográfica
L. Gutiérrez-Rojas, J.J. de la Gándara Martín, L. García Buey et al. Patients with severe mental illness and hepatitis C virus infection benefit from new pangenotypic direct-acting antivirals: Results of a literature review .Gastroenterología y Hepatología 46 (2023) 382---396[https://doi.org/10.1016/j.gastrohep.2022.06.001]





